Celecoxib Use in Gastric Bypass Patients

Introduction to Celecoxib Therapy

The American Gastroenterological Association recommends combining celecoxib with a proton pump inhibitor in high-risk patients, which gastric bypass patients inherently are due to their altered anatomy 1
The American College of Cardiology recommends avoiding celecoxib entirely in patients with established cardiovascular disease, congestive heart failure, or elevated cardiovascular risk 1

Celecoxib increases blood pressure by approximately 5 mm Hg and carries a dose-dependent cardiovascular risk 1
The National Kidney Foundation advises avoiding celecoxib in patients with renal disease or when combining with ACE inhibitors and beta blockers, as approximately 2% of patients develop renal complications requiring discontinuation 1
All NSAIDs can cause volume-dependent renal failure, interstitial nephritis, and nephrotic syndrome through prostaglandin synthesis inhibition 2

The American Heart Association recommends using the lowest effective dose for the shortest duration necessary to minimize cardiovascular and GI risk 4
If high CV risk, established CVD, CHF, or significant renal impairment exists: Do not prescribe celecoxib; consider acetaminophen or topical NSAIDs instead 1, 3

PPIs reduce endoscopic NSAID-related ulcers by approximately 90% and decrease bleeding ulcer rates from 18.8% to 4.4% in high-risk patients 3

The American Geriatrics Society recommends avoiding celecoxib entirely in elderly patients with cardiovascular disease, heart failure, or renal impairment 1, 3
GI bleeding risk increases dramatically with age: 1 in 110 for adults >75 years versus 1 in 2,100 for adults <45 years 1, 3

Acetaminophen should be considered first-line for pain management in patients with high CV risk or contraindications to celecoxib 3
Topical NSAIDs may provide localized pain relief with fewer systemic adverse effects for appropriate conditions 3
Non-pharmacologic approaches should be maximized before initiating any NSAID therapy 3